Cagrilintide acts on calcitonin-related receptors that can influence some glucagon-adjacent signaling, but through a different mechanism
Studies examining thymosin beta-4 biology also report roles in endothelial function and reparative cell activity, further connecting actin-regulated processes with vascular and regenerative signaling [7]
0.25 to 0.5 mg daily, subcutaneous near injury 2.5 mg twice weekly (5 mg total) for weeks 1-4 2.0 to 2.5 mg weekly for weeks 5-8 6 to 8 weeks total Use separate vials and syringes
Tatem AJ, Beilan J, Kovac JR, Lipshultz LI
Products marked research use only may have uncertain identity, purity, potency, sterility, or storage
Possible irregularity from rapid weight loss